Operating Expenses Changement Date
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Enanta Pharmaceuticals USD 49.96M 5.64M 2023-09
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Insmed USD 261.96M 35.22M 2023-12
J&J USD 16.57B 435M 2023-12
Lexicon Pharmaceuticals USD 49.79M 5.24M 2023-09
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Moderna USD 2.8B 1.04B 2023-12
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Takeda JPY 1.09T 202.38B 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vanda Pharmaceuticals USD 48.92M 11.57M 2023-06
Veracyte USD 133.71M 11.86M 2023-12



Vanda Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.